I agree. once the study results are updated with the remaining 30 day data, it can be added to any application necessary, specifically the pivotal trial.
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-51
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.12 |
Change
-0.030(0.49%) |
Mkt cap ! $94.85M | |||
| Open | High | Low | Value | Volume |
| $6.21 | $6.21 | $6.00 | $16.53K | 2.704K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $6.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.08 | 240 | 1 |
View Market Depth
| Last trade - 15.46pm 25/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |